CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-20 | Haurwitz Rachel E. President and CEO | Grant or award | +151,700 | 447,150 | ||
| 2026-02-20 | Haurwitz Rachel E. President and CEO | Grant or award · Option to purchase Common Stock | +682,500 | 682,500 | ||
| 2026-02-20 | Braunstein Scott Director | Grant or award · Option to purchase Common Stock | +45,000 | 45,000 | ||
| 2026-02-20 | GUGGENHIME ANDREW Director | Grant or award · Option to purchase Common Stock | +45,000 | 45,000 | ||
| 2025-03-14 | Haurwitz Rachel E. President and CEO | Purchase | +20,000 | $1.02 | $20K | 3,369,395 |
| 2025-02-21 | Khan Ruhi Ahmad Chief Business Officer | Sale | −3,564 | $1.35 | $5K | 66,936 |
| 2025-02-21 | Kanner Steven Chief Scientific Officer | Sale | −3,564 | $1.35 | $5K | 431,556 |
| 2025-02-21 | MCCLUNG BARBARA G Chief Legal Officer | Sale | −3,564 | $1.35 | $5K | 443,502 |
| 2025-02-20 | Albertson Tina M. Chief Medical Officer | Grant or award | +14,589 | 14,589 | ||
| 2025-02-20 | Albertson Tina M. Chief Medical Officer | Grant or award · Option to purchase Common Stock | +66,137 | 66,137 | ||
| 2025-02-20 | Richardson-Heron Dara Director | Grant or award · Option to purchase Common Stock | +40,500 | 40,500 | ||
| 2025-02-20 | Khan Ruhi Ahmad Chief Business Officer | Grant or award | +37,500 | 70,500 | ||
| 2025-02-20 | Khan Ruhi Ahmad Chief Business Officer | Grant or award · Option to purchase Common Stock | +170,000 | 170,000 | ||
| 2025-02-20 | Zheng Ran Director | Grant or award · Option to purchase Common Stock | +40,500 | 40,500 | ||
| 2025-02-20 | Whiting Nancy Director | Grant or award · Option to purchase Common Stock | +40,500 | 40,500 | ||
| 2025-02-20 | Kanner Steven Chief Scientific Officer | Grant or award | +37,500 | 435,120 | ||
| 2025-02-20 | Kanner Steven Chief Scientific Officer | Grant or award · Option to purchase Common Stock | +170,000 | 170,000 | ||
| 2025-02-20 | Kelly Timothy P Chief Technology Officer | Grant or award | +37,500 | 37,500 | ||
| 2025-02-20 | Kelly Timothy P Chief Technology Officer | Grant or award · Option to purchase Common Stock | +170,000 | 170,000 | ||
| 2025-02-20 | JOHNSON DAVID LEE Director | Grant or award · Option to purchase Common Stock | +40,500 | 40,500 |
Page 2 of 9 · 177 trades